Skip to main content

Full Schedule

Full Schedule

  • Friday, October 25, 2024
  • 8:00 AM – 9:00 AM US PDT
    Coffee & Compatibility LIVE!
    Speaker: Anne Halpin, PhD, A(ACHI) – University of Alberta
    Speaker: Annette Jackson, PhD – Duke University
    Coffee and Compatibility is a monthly ASHI Podcast discussing current topics and expert opinions relating to transplantation, histocompatibility and immunogenetics. The podcast will include personal interviews from the American Society of Histocompatibility and Immunogenetics (ASHI) members, ASHI leadership, intriguing ASHI personalities, and discussions of current trends in transplantation.
  • 9:00 AM – 10:30 AM US PDT
    Plenary V: The Role of HLA Matching in Allogenetic Cellular Therapies
    Speaker: Colleen Delaney, MD, MSc – Deverra Therapeutics
    Speaker: Heather Stefanski, MD PhD – NMDP
    Moderator: Melody Zhang, MD, A(ACHI) – Stanford University
    Moderator: Abeer Madbouly, PhD – NMDP
    Co-Chair: Abeer Madbouly, PhD – NMDP
    Co-Chair: Jerry Morris, MD, PhD, A(ACHI) – University of California San Diego
    As the field of cellular therapies evolves, allogeneic therapies are quickly growing and becoming very attractive due to the plethora of available cell sources and the flexibility of building off-the-shelf cell banks. However, histocompatibility between the cell donors and therapy recipients plays an important factor. In particular, the role of HLA matching is unclear in impacting the success of multiple cellular therapies, when to account for it, when to avoid and when to take particular considerations. This session will touch on some recent advances in allogeneic cellular therapies and discuss some important histocompatibility issues cellular therapy developers and testing labs are facing through the experiences of some esteemed experts in the field.
  • 10:30 AM – 12:00 PM US PDT
    Closing Session: Is your Lab Ready for Xenotransplantation?
    Speaker: Sam Ho, PhD, F(ACHI), FADLM – Gift of Hope Organ & Tissue Donor Network
    Speaker: Julie Houp, MS, CHS – University of Alabama at Birmingham
    Speaker: Joseph Ladowski – Duke University
    Speaker: Massimo Mangiola, PhD, A(ACHI) – NYU Langone Health
    Moderator: Doreen Sese, CHS – NYU Langone | Transplant Institute
    Co-Chair: Anne Halpin, PhD, A(ACHI) – University of Alberta
    Co-Chair: Luis Hidalgo, PhD, F(ACHI) – University of Wisconsin HLA Laboratory
    Co-Chair: James Lan, MD, FRCPC, D(ACHI) – University of British Columbia
    Co-Chair: Rob Liwski, MD, PhD, FRCPC, F(ACHI) – Dalhousie University
    Xenotransplantation, long regarded as the perpetual future of organ transplantation, has recently undergone a notable resurgence. In the past five years, we have seen the clinical application of heart and kidney xenografts in human recipients. If successful, this approach has the potential to not only alleviate the critical shortage of transplantable organs but also present new challenges and opportunities for the transplantation and histocompatibility communities. Key among these challenges is determining how to select and effectively match patients with genetically engineered pig donors. In this session, we will examine the clinical need for xenotransplantation, the complexities and challenges of using pigs as organ donors, current strategies for assessing histocompatibility in the context of xenotransplantation, and future directions for xenocompatibility testing.